Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) CEO Brady Patrick Priest sold 75,000 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $3.68, for a total value of $276,000.00. Following the completion of the sale, the chief executive officer now owns 2,418,151 shares of the company's stock, valued at approximately $8,898,795.68. This trade represents a 3.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Clover Health Investments Stock Performance
Shares of Clover Health Investments stock traded down $0.03 during trading on Tuesday, reaching $3.36. 7,389,169 shares of the company's stock were exchanged, compared to its average volume of 6,444,964. Clover Health Investments, Corp. has a 1-year low of $0.61 and a 1-year high of $4.87. The company has a market cap of $1.72 billion, a P/E ratio of -16.80 and a beta of 2.00. The firm's 50-day moving average price is $4.09 and its 200 day moving average price is $3.62.
Analysts Set New Price Targets
A number of analysts have recently weighed in on the company. Canaccord Genuity Group upped their target price on Clover Health Investments from $4.20 to $4.50 and gave the company a "buy" rating in a research report on Monday, March 3rd. Craig Hallum assumed coverage on shares of Clover Health Investments in a report on Tuesday, December 17th. They issued a "buy" rating and a $6.00 target price on the stock.
Check Out Our Latest Research Report on CLOV
Hedge Funds Weigh In On Clover Health Investments
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Jefferies Financial Group Inc. bought a new stake in shares of Clover Health Investments during the fourth quarter worth about $135,000. Mackenzie Financial Corp boosted its position in Clover Health Investments by 211.3% during the fourth quarter. Mackenzie Financial Corp now owns 78,193 shares of the company's stock valued at $246,000 after acquiring an additional 53,076 shares during the last quarter. Alpine Global Management LLC acquired a new stake in Clover Health Investments during the fourth quarter worth approximately $226,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Clover Health Investments by 90.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 830,457 shares of the company's stock worth $2,616,000 after purchasing an additional 394,881 shares in the last quarter. Finally, Two Sigma Advisers LP acquired a new position in Clover Health Investments in the fourth quarter valued at approximately $78,000. Institutional investors own 19.77% of the company's stock.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Further Reading
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
